Market Size of North America Biopsy Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 0.86 Billion |
| Market Size (2029) | USD 1.05 Billion |
| CAGR (2024 - 2029) | 4.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Biopsy Devices Market Analysis
The North America Biopsy Devices Market size is estimated at USD 0.86 billion in 2024, and is expected to reach USD 1.05 billion by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).
The major factors driving the growth of the market in the North America region is due to the increasing preference for minimally invasive procedures, an increase in the number of cancer cases, and initiatives undertaken by the government for early diagnosis of cancer.
Biopsy has been one of the major diagnosis techniques for cancer disorders and is widely used in the diagnosis of breast, skin, and prostate cancer. According to the Canadian Cancer Statistics 2019 report, it is estimated that nearly 1 in 2 Canadians will be diagnosed with cancer in their lifetime. An estimated 220,400 new cases of cancer are diagnosed in Canada in 2019. The number of cases in males (113,000) was expected to be slightly higher than in females (107,400).
There is also a demand for minimally invasive biopsy procedures that is rising at a significant rate in the market. The different types of technologies and products, such as biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to witness the high growth during the forecast period. Thus, owing to above mentioned factors the market is expected to show significant growth over the forecast period.
North America Biopsy Devices Industry Segmentation
As per the scope of the report, the biopsy is a process that helps in the removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissues. Therefore, the biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. The North America Biopsy Devices Market is segmented by product, application, and geography.
| By Product | |||||
| |||||
| Procedure Trays | |||||
| Localization Wires | |||||
| Other Products |
| By Application | |
| Breast Biopsy | |
| Lung Biopsy | |
| Colorectal Biopsy | |
| Prostate Biopsy | |
| Other Applications |
| Geography | |||||
|
North America Biopsy Devices Market Size Summary
The North America Biopsy Devices Market is poised for growth, driven by the increasing preference for minimally invasive procedures and a rising incidence of cancer cases. This market is characterized by the widespread use of biopsy techniques in diagnosing various cancers, including breast, skin, and prostate cancers. The demand for advanced biopsy technologies, such as biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices, is expected to rise significantly. Needle-based biopsy devices, in particular, are leading the market due to their effectiveness in obtaining samples from soft tissues of internal organs. This trend is supported by government initiatives aimed at early cancer diagnosis, further propelling market expansion.
The competitive landscape of the North America Biopsy Devices Market is fragmented, with key players like Hologic, Becton, Dickinson and Company, and Boston Scientific Corporation actively participating. These companies are focusing on strategic initiatives such as technological innovations, product launches, and partnerships to enhance their market presence and profitability. The market's growth trajectory is supported by the increasing demand for minimally invasive procedures, which is expected to continue driving the adoption of biopsy devices across the region. As a result, the market is anticipated to experience significant growth over the forecast period, with a steady increase in market size and share.
North America Biopsy Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Preference for Minimally Invasive Procedures
-
1.2.2 Increase in the Number of Cancer Cases Worldwide
-
1.2.3 Initiatives Undertaken by Government for Diagnosis
-
-
1.3 Market Restraints
-
1.3.1 Product Recalls
-
1.3.2 Availability of Alternative Techniques
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Needle-based Biopsy Instruments
-
2.1.1.1 Core Biopsy Devices
-
2.1.1.2 Aspiration Biopsy Needles
-
2.1.1.3 Vacuum-assisted Biopsy Devices
-
-
2.1.2 Procedure Trays
-
2.1.3 Localization Wires
-
2.1.4 Other Products
-
-
2.2 By Application
-
2.2.1 Breast Biopsy
-
2.2.2 Lung Biopsy
-
2.2.3 Colorectal Biopsy
-
2.2.4 Prostate Biopsy
-
2.2.5 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
-
North America Biopsy Devices Market Size FAQs
How big is the North America Biopsy Devices Market?
The North America Biopsy Devices Market size is expected to reach USD 0.86 billion in 2024 and grow at a CAGR of 4% to reach USD 1.05 billion by 2029.
What is the current North America Biopsy Devices Market size?
In 2024, the North America Biopsy Devices Market size is expected to reach USD 0.86 billion.
